|
Measuring HIV Neutralization in a Luciferase Reporter Gene Assay
|
book
|
January 2009 |
|
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
|
journal
|
February 2014 |
|
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
|
journal
|
July 2014 |
|
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
|
journal
|
June 2015 |
|
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
|
journal
|
April 2016 |
|
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
|
journal
|
May 2016 |
|
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires
|
journal
|
September 2016 |
|
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site
|
journal
|
January 2016 |
|
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
|
journal
|
March 2016 |
|
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
|
journal
|
August 2016 |
|
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
|
journal
|
April 2017 |
|
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
|
journal
|
August 2017 |
|
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model
|
journal
|
October 2017 |
|
Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 Strains
|
journal
|
November 2009 |
|
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
|
journal
|
September 2012 |
|
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
|
journal
|
November 2015 |
|
Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch
|
journal
|
May 2016 |
|
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
|
journal
|
September 2016 |
|
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
|
journal
|
June 2017 |
|
Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development
|
journal
|
September 2017 |
|
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
|
journal
|
July 2014 |
|
Structural principles controlling HIV envelope glycosylation
|
journal
|
June 2017 |
|
Microsecond Dynamics and Network Analysis of the HIV-1 SOSIP Env Trimer Reveal Collective Behavior and Conserved Microdomains of the Glycan Shield
|
journal
|
October 2017 |
|
Virological features associated with the development of broadly neutralizing antibodies to HIV-1
|
journal
|
April 2015 |
|
A rev1–vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev–vpu–env cassettes and reduces virion infectivity in pseudotyping assays
|
journal
|
February 2010 |
|
Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins
|
journal
|
September 2009 |
|
Antibody neutralization and escape by HIV-1
|
journal
|
March 2003 |
|
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
|
journal
|
November 2011 |
|
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
|
journal
|
April 2013 |
|
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
|
journal
|
March 2014 |
|
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
journal
|
October 2014 |
|
Global site-specific N-glycosylation analysis of HIV envelope glycoprotein
|
journal
|
March 2017 |
|
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
|
journal
|
October 2012 |
|
Early development of broadly neutralizing antibodies in HIV-1–infected infants
|
journal
|
May 2014 |
|
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
|
journal
|
October 2015 |
|
Determinants of HIV-1 broadly neutralizing antibody induction
|
journal
|
September 2016 |
|
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
|
journal
|
August 2013 |
|
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
|
journal
|
December 2015 |
|
Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site
|
journal
|
September 2016 |
|
Conformational Heterogeneity of the HIV Envelope Glycan Shield
|
journal
|
June 2017 |
|
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
|
journal
|
December 2005 |
|
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
|
journal
|
March 2003 |
|
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
|
journal
|
May 2008 |
|
Phenotypic properties of transmitted founder HIV-1
|
journal
|
March 2013 |
|
Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness
|
journal
|
January 2017 |
|
Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response
|
journal
|
November 2004 |
|
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
|
journal
|
June 2009 |
|
Innate Sensing of HIV-1 by Dendritic Cell-Specific ICAM-3 Grabbing Nonintegrin on Dendritic Cells: Degradation and Presentation Versus Transmission of Virus to T Cells Is Determined by Glycan Composition of Viral Envelope
|
journal
|
August 2017 |
|
Clustal W and Clustal X version 2.0
|
journal
|
September 2007 |
|
Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data
|
journal
|
April 2012 |
|
RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
|
journal
|
January 2014 |
|
Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin
|
journal
|
July 2004 |
|
A transient three-plasmid expression system for the production of high titer retroviral vectors
|
journal
|
January 1995 |
|
Specificity of the autologous neutralizing antibody response
|
journal
|
January 2009 |
|
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
|
journal
|
January 2014 |
|
Germline-targeting immunogens
|
journal
|
January 2017 |
|
Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem
|
journal
|
January 2017 |
|
Polyvalent vaccine approaches to combat HIV-1 diversity
|
journal
|
January 2017 |
|
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
|
journal
|
August 2007 |
|
Host Controls of HIV Neutralizing Antibodies
|
journal
|
May 2014 |
|
HIV-1 neutralizing antibodies induced by native-like envelope trimers
|
journal
|
June 2015 |
|
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
|
journal
|
March 2016 |
|
Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies
|
journal
|
June 2016 |
|
Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV
|
journal
|
May 2014 |
|
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies
|
journal
|
March 2017 |
|
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller
|
journal
|
January 2017 |
|
Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression
|
journal
|
October 2009 |
|
Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers
|
journal
|
February 2017 |
|
Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing
|
journal
|
February 2008 |
|
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
|
journal
|
December 2013 |
|
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
|
journal
|
July 2005 |
|
Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas
|
journal
|
April 2015 |
|
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
|
journal
|
May 2016 |
|
Estimating time since infection in early homogeneous HIV-1 samples using a poisson model
|
journal
|
October 2010 |
|
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
|
journal
|
January 2013 |
|
Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein
|
journal
|
October 2016 |
|
HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response
|
journal
|
March 2012 |
|
Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7
|
journal
|
May 2012 |
|
Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape
|
journal
|
May 2012 |
|
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site
|
journal
|
May 2015 |
|
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
|
journal
|
January 2016 |
|
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
|
journal
|
July 2016 |
|
Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
|
journal
|
September 2016 |
|
Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth
|
journal
|
November 2016 |
|
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants
|
journal
|
October 2015 |
|
HIV-1 N -Glycan Composition Governs a Balance between Dendritic Cell-Mediated Viral Transmission and Antigen Presentation
|
journal
|
September 2011 |